Showing 69,541 - 69,560 results of 105,386 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( e ((fold decrease) OR (point decrease)) ))', query time: 1.76s Refine Results
  1. 69541
  2. 69542
  3. 69543
  4. 69544

    Development and fusion of the posterior ganglion anlagen of <i>Pseudopallene</i> sp. by Georg Brenneis (552078)

    Published 2014
    “…<p>Acetylated tubulin (black, red)- and PH3 (yellow)-labeled VNCs with Hoechst (blue) counterstain (<b>A–D</b>) and histological sections (<b>E–G</b>). <b>A–C</b>: Ventral views of the posterior ganglion anlagen, Imaris volume (MIP). …”
  5. 69545

    Competition assay between VHHs. by Lorena Garaicoechea (782611)

    Published 2015
    “…<p>The images show immunofluorescence staining of Vero cells expressing NoV VP1 from Norwalk strain (a) or MD2004 strain (b). …”
  6. 69546

    Hydrogen Production via Ethanol Decomposition over Bimetallic Catalyst by Ashok, Anchu

    Published 2016
    “…Out of these, decomposition technique is a low temperature process and suitable for small scale fuel cell applications e.g. charging cell phones, computers etc. …”
    Get full text
    Get full text
  7. 69547

    Task-related hemodynamic responses are modulated by reward and task engagement by Mariana M. B. Cardoso (6615959)

    Published 2019
    “…With higher rewards, animals appeared more task-engaged; task-related responses were more temporally precise at the task period (approximately 10–20 seconds) and modestly stronger. The 2–5 minute blocks of high-reward trials led to ramp-like decreases in mean local blood volume; these reversed with ramp-like increases during low reward. …”
  8. 69548

    Detection of relevant pharmacogenetic information through exome sequencing in oncology: Supplementary tables by Simon Verdez (13543819)

    Published 2022
    “…Materials</p> <p>& methods: To evaluate the interest of such pharmacogenetic information, the authors retrospectively</p> <p>analyzed genes known to have an impact on cancer therapy in a cohort of 445 solid cancers patients.</p> <p>Results: Six patients treated with 5-fluorouracil carrying one DPYD variant classified as 1A showed</p> <p>decreased drug mean clearance (p = 0.01). …”
  9. 69549

    L1 overexpression in SENAs reduces the scar volume after transplantation into the compression-lesioned spinal cord of adult mice. by Yi-Fang Cui (227234)

    Published 2011
    “…Mean relative scar volumes ± SEM are displayed in the diagram (L1, n = 7; WT, n = 7, PBS, n = 5). …”
  10. 69550

    Cluster of differentially expressed genes during broccoli seed germination and sprout development. by Jinjun Gao (528119)

    Published 2014
    “…<p>Expression changes and cluster analysis of 2675 genes that were differentially expressed between any two of the five samples. Each row represents a differentially expressed gene, while each column represents a sample. …”
  11. 69551

    Beta GAM modelling on the relationship between the proportion of remaining forest cover at the municipality level and socio-economic factors. by Raúl Abel Vaca (144236)

    Published 2012
    “…The trend is approximately linear on a log scale, so the gradient decreases along this part of the trajectory when the curve is plotted on a linear scale. …”
  12. 69552

    Analysis of slipped-DNA in native chromatin, and EM of IP'd DNA. by Michelle M. Axford (269322)

    Published 2013
    “…Also, see <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1003866#pgen.1003866.s005" target="_blank">Figure S5C</a> for a comparison of areas under each peak of the GeneScans before and after treatment. …”
  13. 69553
  14. 69554
  15. 69555
  16. 69556
  17. 69557

    Table_1_Population Pharmacokinetics and Pharmacodynamics Modeling of Torasemide and Furosemide After Oral Repeated Administration in Healthy Dogs.pdf by Ludovic Pelligand (3955772)

    Published 2020
    “…The aim of this pharmacokinetic-pharmacodynamic (PK/PD) study was to define an optimally effective dosage regimen based on preclinical data. In a first study, 5 dogs received once-daily oral torasemide (0, 0.1, 0.2, 0.4, 0.8 mg/kg/day) for 14 days. …”
  18. 69558

    Table_2_Population Pharmacokinetics and Pharmacodynamics Modeling of Torasemide and Furosemide After Oral Repeated Administration in Healthy Dogs.pdf by Ludovic Pelligand (3955772)

    Published 2020
    “…The aim of this pharmacokinetic-pharmacodynamic (PK/PD) study was to define an optimally effective dosage regimen based on preclinical data. In a first study, 5 dogs received once-daily oral torasemide (0, 0.1, 0.2, 0.4, 0.8 mg/kg/day) for 14 days. …”
  19. 69559
  20. 69560

    Crosstalk between IIS and TGF-β signaling pathways. by Sri Devi Narasimhan (223914)

    Published 2011
    “…For the dauer assays, error bars indicate the standard deviation among the different plates within one experiment. (A) Lifespan graph showing the opposite effects of <i>daf-3</i> and <i>daf-5</i> mutations in a <i>daf-2(e1370)</i> background. …”